Literature DB >> 25731622

Amyloid β accumulation assessed with ¹¹C-Pittsburgh compound B PET and postmortem neuropathology.

Hiroyuki Hatsuta, Masaki Takao, Kenji Ishii, Kiichi Ishiwata, Yuko Saito, Kazutomi Kanemaru, Tomio Arai, Tetsuya Suhara, Hitoshi Shimada, Hitoshi Shinotoh, Akira Tamaoka, Shigeo Murayama.   

Abstract

¹¹C-Pittsburgh compound B (PiB) uptake in PET images is frequently used to analyze β amyloid (Aβ) deposition in living individuals, but its correlation with histologically determined Aβ has not been examined. Six individuals with dementia underwent PiB-PET imaging, and their brains were analyzed neuropathologically (mean interval between imaging and death: 816 days; PiB positive:negative, 3:3; male:female, 3:3; mean age: 84.0 years). PiB uptake (reported as standardized uptake value ratio [SUVR]) was analyzed in 11 cortical regions and 10 subcortical grey matter areas and compared with the Aβ load (% area [the percentage of total area positive for Aβ] and number of neuritic plaques) seen with immunohistochemical staining with an anti-Aβ 11-28 antibody. Two PiB-positive subjects had abundant neuritic plaques and were diagnosed with Alzheimer’s disease (AD). SUVR and % area were strongly correlated in the cortical regions of these subjects (subject 1: r = 0.65, p = 0.03; subject 2: r = 0.80, p = 0.003). The other PiBpositive subject (subject 3) showed focal PiB uptake. In subject 3 and the 3 PiB-negative subjects (subjects 4-6), there was no correlation between regional SUVR and % area or neuritic plaques. PiB uptake was not correlated with Aβ deposition in subcortical regions. High PiB positivity in the cerebral cortex suggests the presence of substantial Aβ deposition and neuritic plaques associated with the pathologic changes of AD. Our results suggest that high cortical SUVR is a reliable marker of AD. Subcortical PiB positivity must be interpreted more carefully.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25731622     DOI: 10.2174/1567205012666150302155930

Source DB:  PubMed          Journal:  Curr Alzheimer Res        ISSN: 1567-2050            Impact factor:   3.498


  6 in total

Review 1.  Neuropathological correlates of amyloid PET imaging in Down syndrome.

Authors:  Eric E Abrahamson; Elizabeth Head; Ira T Lott; Benjamin L Handen; Elliott J Mufson; Bradley T Christian; William E Klunk; Milos D Ikonomovic
Journal:  Dev Neurobiol       Date:  2019-08-17       Impact factor: 3.964

2.  Patterns of Cortical and Subcortical Amyloid Burden across Stages of Preclinical Alzheimer's Disease.

Authors:  Emily C Edmonds; Katherine J Bangen; Lisa Delano-Wood; Daniel A Nation; Ansgar J Furst; David P Salmon; Mark W Bondi
Journal:  J Int Neuropsychol Soc       Date:  2016-11       Impact factor: 2.892

3.  Regional brain hypometabolism is unrelated to regional amyloid plaque burden.

Authors:  Andre Altmann; Bernard Ng; Susan M Landau; William J Jagust; Michael D Greicius
Journal:  Brain       Date:  2015-09-29       Impact factor: 13.501

4.  Proactive Semantic Interference is Associated with Total and Regional Abnormal Amyloid Load in Non-Demented Community-Dwelling Elders: A Preliminary Study.

Authors:  David A Loewenstein; Maria T Greig; Rosie Curiel; Rosemarie Rodriguez; Meredith Wicklund; Warren W Barker; Jacqueline Hidalgo; Marian Rosado; Ranjan Duara
Journal:  Am J Geriatr Psychiatry       Date:  2015-07-26       Impact factor: 4.105

5.  Negative 11C-PIB PET Predicts Lack of Alzheimer's Disease Pathology in Postmortem Examination.

Authors:  Noora M Scheinin; Maria Gardberg; Matias Röyttä; Juha O Rinne
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

6.  Post-mortem analyses of PiB and flutemetamol in diffuse and cored amyloid-β plaques in Alzheimer's disease.

Authors:  Milos D Ikonomovic; Christopher J Buckley; Eric E Abrahamson; Julia K Kofler; Chester A Mathis; William E Klunk; Gill Farrar
Journal:  Acta Neuropathol       Date:  2020-08-09       Impact factor: 17.088

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.